World's first '384' code reader
Absolute Vision is to launch what is claimed to be the world's first solution to read Data Matrix codes on 384 rack-mounted sample storage-tubes.
Archives for October 13, 2003
Pyrosequencing buys Biotage in US
Sweden's Pyrosequencing has entered into an agreement to buy prification and separation specialist Biotage, a subsidiary of Dyax of the USA, for $35 million.
Chugai to claim top spot for bio production
Chugai says it is building facilities that will give it the largest bioreactor capacity for biologicals production - at 85,000L - of any company in the world by 2007.
Tentacle tech from Merck
Germany's Merck has introduced a new process media for the capture of viruses, proteins, antibodies and DNA that has significant advantages over other sorbents.
Fighting antibiotic resistance from within
Ipsat Therapies has completed a Phase I trial of a novel approach to preventing bacterial resistance by de-activating antibiotics in the gastrointestinal tract.
Natural compound collaboration
Evotec OAI and Biofrontera Pharmaceuticals have entered into a co-marketing and distribution agreement to offer natural compound libraries for drug discovery.
Towards harmonisation in chemical analysis
European groups involved in developing and supplying reference materials for chemical analysis have reached agreement on the new ERM Initiative.
Applera sues Roche over PCR
Switzerland's Roche is subject to a fresh legal challenge over its patent position in polymerase chain reaction (PCR) testing, this time from Applera unit Applied Biosystems.
Ireland's DPS sets out on European charge
DPS Engineering, an Irish engineering firm which specialises in providing services to the pharmaceutical sector says it is planning to create 250 jobs over the next five years as it continues a major growth phase in its business in mainland Europe.
Roche to build $155m PCR facility
Roche is planning to spend $155 million on a new polymerase chain reaction (PCR) manufacturing centre at its site in Branchburg, New Jersey.